Back to search

Article

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

2022-09-22

Abstract excerpt

The primary two-dose SARS-CoV-2 mRNA vaccine series are strongly immunogenic in humans, but the emergence of highly infectious variants necessitated additional doses of these vaccines and the development of new variant-derived ones 1–4 . SARS-CoV-2 booster immunizations in humans primarily recruit pre-existing memory B cells (MBCs) 5–9 . It remains unclear, however, whether the additional doses induce germinal c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c36ff495-27a2-5197-9280-c0c92e2dbcc1
DOI
10.1101/2022.09.22.509040
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SARS-CoV-2 Omicron boosting induces de novo B cell response in humansDOI 10.1101/2022.09.22.509040
Select a neighboring publication to make it the new centre.